Notably, and in clear contrast to HLA‐DR expression which was restricted to CD3+CD8+ T cells, significant upregulation of CD38 on lymphocytes of COVID‐19 convalescent patients was observed on both, CD4+ and CD8+ T cells (Table S3). This evidence concerns the gene CD8A and COVID-19.